Levetiracetam Alters Oscillatory Connectivity in Alzheimer’s Disease

Hauser, 1986, Seizures and myoclonus in patients with Alzheimer’sdisease, Neurology, 36, 1226, 10.1212/WNL.36.9.1226

Volicer, 1995, Effect of seizures on progression of dementia of the Alzheimer type, Dementia, 6, 258

Palop, 2009, Epilepsy and cognitive impairments in Alzheimer disease, Arch Neurol, 66, 435, 10.1001/archneurol.2009.15

Amatniek, 2006, Incidence and predictors of seizures in patients with Alzheimer’s disease, Epilepsia, 47, 867, 10.1111/j.1528-1167.2006.00554.x

Romanelli, 1990, Advanced Alzheimer’s disease is a risk factor for late-onset seizures, Arch Neurol, 47, 847, 10.1001/archneur.1990.00530080029006

Mendez, 2003, Seizures in elderly patients with dementia: Epidemiology and management, Drugs Aging, 20, 791, 10.2165/00002512-200320110-00001

Scarmeas, 2009, Seizures in Alzheimer disease: Who, when, and how common?, Arch Neurol, 66, 992, 10.1001/archneurol.2009.130

Rao, 2009, Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome, Epilepsy Behav, 14, 118, 10.1016/j.yebeh.2008.08.012

Bernardi, 2010, Seizures in Alzheimer’s disease: A retrospective study of a cohort of outpatients, Epileptic Disord, 12, 16, 10.1684/epd.2010.0290

Lozsadi, 2006, Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer’s disease, Dement Geriatr Cogn Disord, 22, 121, 10.1159/000093664

Vossel, 2016, Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease, Ann Neurol, 80, 858, 10.1002/ana.24794

Mucke, 2012, Neurotoxicity of amyloid beta-protein: Synatic and network dysfunction, Cold Spring Harb Perspect Med, 2, a006338, 10.1101/cshperspect.a006338

Sanchez, 2012, Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model., E, Proc Natl Acad Sci U S A, 109, 2895, 10.1073/pnas.1121081109

Shi, 2013, Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice, CNS Neurosci Ther, 19, 871, 10.1111/cns.12144

Gorji, 2002, Effect of levetiracetam on epileptiform discharges in human neocortical slices, Epilepsia, 43, 1480, 10.1046/j.1528-1157.2002.23702.x

Larsson, 2010, Decrease in propagation of interictal epileptiform activity after introduction of levetiracetam visualized with electric source imaging, Brain Topogr, 23, 269, 10.1007/s10548-010-0150-1

Lynch, 2004, The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam, Proc Natl Acad Sci U S A, 101, 9861, 10.1073/pnas.0308208101

Cho, 2012, Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naive epilepsy patients, Clin Neurophysiol, 123, 883, 10.1016/j.clinph.2011.09.012

Stodieck, 2001, Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges, Seizure, 10, 583, 10.1053/seiz.2001.0582

Bakker, 2012, Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment, Neuron, 74, 467, 10.1016/j.neuron.2012.03.023

Lippa, 2010, Levetiracetam: A practical option for seizure management in elderly patients with cognitive impairment, Am J Alzheimers Dis Other Demen, 25, 149, 10.1177/1533317508325095

Coben, 1985, A longitudinal EEG study of mild senile dementia of Alzheimer type: Changes at 1 year and at 2.5 years, Electroencephalogr Clin Neurophysiol, 61, 101, 10.1016/0013-4694(85)91048-X

Jeong, 2004, EEG dynamics in patients with Alzheimer’s disease, Clin Neurophysiol, 115, 1490, 10.1016/j.clinph.2004.01.001

Duffy, 1984, Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type, Ann Neurol, 16, 439, 10.1002/ana.410160404

Breslau, 1989, Topographic EEG changes with normal aging and SDAT, Electroencephalogr Clin Neurophysiol, 72, 281, 10.1016/0013-4694(89)90063-1

Roh, 2011, Region and frequency specific changes of spectral power in Alzheimer’s disease and mild cognitive impairment, Clin Neurophysiol, 122, 2169, 10.1016/j.clinph.2011.03.023

Sankari, 2011, Intrahemispheric, interhemispheric, and distal EEG coherence in Alzheimer’s disease, Clin Neurophysiol, 122, 897, 10.1016/j.clinph.2010.09.008

Locatelli, 1998, EEG coherence in Alzheimer’s disease, Electroencephalogr Clin Neurophysiol, 106, 229, 10.1016/S0013-4694(97)00129-6

Jelles, 2008, Global dynamical analysis of the EEG in Alzheimer’s disease: Frequency-specific changes of functional interactions, Clin Neurophysiol, 119, 837, 10.1016/j.clinph.2007.12.002

Besthorn, 1994, EEG coherence in Alzheimer disease, Electroencephalogr Clin Neurophysiol, 90, 242, 10.1016/0013-4694(94)90095-7

Babiloni, 2004, Cortical networks generating movement-related EEG rhythms in Alzheimer’s disease: An EEG coherence study, Behav Neurosci, 118, 698, 10.1037/0735-7044.118.4.698

Jelic, 2000, Quantitative electroencephalography in mild cognitive impairment: Longitudinal changes and possible prediction of Alzheimer’s disease, Neurobiol Aging, 21, 533, 10.1016/S0197-4580(00)00153-6

Rossini, 2006, Conversion from mild cognitive impairment to Alzheimer’s disease is predicted by sources and coherence of brain electroencephalography rhythms, Neuroscience, 143, 793, 10.1016/j.neuroscience.2006.08.049

Buckles, 2003, Understanding of informed consent by demented individuals, Neurology, 61, 1662, 10.1212/01.WNL.0000098933.34804.FC

Yesavage, 1982, Development and validation of a geriatric depression screening scale: A preliminary report, J Psychiatr Res, 17, 37, 10.1016/0022-3956(82)90033-4

Grober, 2010, Free and cued selective reminding identifies very mild dementia in primary care, Alzheimer Dis Assoc Disord, 24, 284, 10.1097/WAD.0b013e3181cfc78b

Delorme, 2004, EEGLAB: An open source toolbox for analysis of single-trial EEG dynamics including independent component analysis, J Neurosci Methods, 134, 9, 10.1016/j.jneumeth.2003.10.009

Lee, 1999, Independent component analysis using an extended infomax algorithm for mixed subgaussian and supergaussian sources, Neural Comput, 11, 417, 10.1162/089976699300016719

Gourovitch, 2000, A comparison of rCBF patterns during letter and semantic fluency, Neuropsychology, 14, 353, 10.1037/0894-4105.14.3.353

Xia, 2013, BrainNet Viewer: A network visualization tool for human brain connectomics, PLoS One, 8, e68910, 10.1371/journal.pone.0068910

Brunovsky, 2003, Objective assessment of the degree of dementia by means of EEG, Neuropsychobiology, 48, 19, 10.1159/000071824

Chen, 2015, Frequency power and coherence of electroencephalography are correlated with the severity of Alzheimer’s disease: A multicenter analysis in Taiwan, J Formos Med Assoc, 114, 729, 10.1016/j.jfma.2013.07.008

Mecarelli, 2004, Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers, Ann Pharmacother, 38, 1816, 10.1345/aph.1E136

Kim, 2015, Changes in background electroencephalography and regional cerebral glucose metabolism in focal epilepsy patients after 1-month administration of levetiracetam, Neuropsychiatr Dis Treat, 11, 215

Bakker, 2015, Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance, Neuroimage Clin, 7, 688, 10.1016/j.nicl.2015.02.009